Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young & Nathorn Chaiyakunapruk. (2023) Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies. Journal of Asthma 60:9, pages 1702-1714.
Read now
Read now
Sajith Kumar & Bhavani Shankara Bagepally. (2023) Cost-effectiveness of tumor necrosis factor-alpha inhibitors: a systematic review and meta-analysis of cost-utility studies. Expert Review of Pharmacoeconomics & Outcomes Research 0:0, pages 1-14.
Read now
Read now
Sariya Udayachalerm, Maranda G. Renouard, Thunyarat Anothaisintawee, Ammarin Thakkinstian, Sajesh K. Veettil & Nathorn Chaiyakunapruk. (2022) Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence. Journal of Medical Economics 25:1, pages 26-37.
Read now
Read now
Anees Shajhan Ebrahem & Mark Oremus. (2018) A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease. Expert Opinion on Pharmacotherapy 19:11, pages 1245-1259.
Read now
Read now
Articles from other publishers (43)
Akhil Sasidharan, Bhavani Shankara Bagepally & S Sajith Kumar. (2023) Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review. Applied Health Economics and Health Policy.
Crossref
Crossref
Wenjia Chen, Nigel Chong Boon Wong, Yi Wang, Yaroslava Zemlyanska, Dimple Butani, Suchin Virabhak, David Bruce Matchar, Thittaya Prapinvanich & Yot Teerawattananon. (2023) Mapping the value for money of precision medicine: a systematic literature review and meta-analysis. Frontiers in Public Health 11.
Crossref
Crossref
Sibo Liu, Daniel SW Tan, Nicholas Graves & Ann-Marie Chacko. (2023) Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review. Applied Health Economics and Health Policy 21:6, pages 841-855.
Crossref
Crossref
Yi Jing Tan, Siew Chin Ong & Ying Min Kan. (2023) Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness Studies. Applied Health Economics and Health Policy 21:6, pages 857-875.
Crossref
Crossref
Sumudu A. Hewage, Rini Noviyani, David Brain, Pakhi Sharma, William Parsonage, Steven M. McPhail, Adrian Barnett & Sanjeewa Kularatna. (2023) Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality. Cost Effectiveness and Resource Allocation 21:1.
Crossref
Crossref
Wenjia Chen, Yi Wang, Yaroslava Zemlyanska, Dimple Butani, Nigel Chong Boon Wong, Suchin Virabhak, David Bruce Matchar & Yot Teerawattananon. (2023) Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges. Value in Health 26:9, pages 1425-1434.
Crossref
Crossref
Jai Vithlani, Claire Hawksworth, Jamie Elvidge, Lynda Ayiku & Dalia Dawoud. (2023) Economic evaluations of artificial intelligence-based healthcare interventions: a systematic literature review of best practices in their conduct and reporting. Frontiers in Pharmacology 14.
Crossref
Crossref
Yoann Sapanel, Xavier Tadeo, Connor T A Brenna, Alexandria Remus, Florian Koerber, L Martin Cloutier, Gabriel Tremblay, Agata Blasiak, Chris L Hardesty, Joanne Yoong & Dean Ho. (2023) Economic Evaluation Associated With Clinical-Grade Mobile App–Based Digital Therapeutic Interventions: Systematic Review. Journal of Medical Internet Research 25, pages e47094.
Crossref
Crossref
Thomas Michael Otten, Sabine E. Grimm, Bram Ramaekers & Manuela A. Joore. (2023) Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations. PharmacoEconomics 41:6, pages 619-632.
Crossref
Crossref
Wai-Chee Kuan, Ruth Sim, Wei Jin Wong, Juman Dujaili, Sazzli Kasim, Kenneth Kwing-Chin Lee & Siew Li Teoh. (2023) Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure with Reduced Ejection Fraction: A Systematic Review. Value in Health.
Crossref
Crossref
Lavanya Ayyasamy & Bhavani Shankara Bagepally. (2023) Cost-utility of Ranolazine for Chronic Stable Angina Pectoris: Systematic Review and Meta-analysis. Clinical Therapeutics 45:5, pages 458-465.
Crossref
Crossref
M. Sakil Syeed, Priyanka Ghule, Lan M. Le, Sajesh K. Veettil, Emily K. Horn, Johnna Perdrizet, Matt Wasserman, Ammarin Thakkinstian & Nathorn Chaiyakunapruk. (2023) Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health 26:4, pages 598-611.
Crossref
Crossref
Phatcharaphorn Chotnoppharatphatthara, Voratima Yoodee, Suthinee Taesotikul, Jirawit Yadee & Unchalee Permsuwan. (2022) Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis: systematic review of cost-effectiveness analysis. The European Journal of Health Economics 24:3, pages 359-376.
Crossref
Crossref
László Lorenzovici, László Szilberhorn, Szabolcs Farkas-Ráduly, Andrea Ildiko Gasparik, Andreea Mihaela Precup, Adél Gyöngyvér Nagy, Carsten Utoft Niemann, Tero Aittokallio, Zoltán Kaló & Marcell Csanádi. (2023) Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs 37:2, pages 219-233.
Crossref
Crossref
Andrew Gallagher, Violetta Shersher, Duncan Mortimer, Helen Truby & Terry Haines. (2022) The Cost-Effectiveness of Adjunctive Lifestyle Interventions for the Management of Cancer: A Systematic Review. Applied Health Economics and Health Policy 21:2, pages 225-242.
Crossref
Crossref
S Sajith Kumar, Bhavani Shankara Bagepally & Akhil Sasidharan. (2023) Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies. Clinical Drug Investigation 43:2, pages 97-108.
Crossref
Crossref
J. Haxby Abbott, Ross Wilson, Yana Pryymachenko, Saurab Sharma, Anupa Pathak & Jason Y. Y. Chua. (2022) Economic evaluation: a reader’s guide to studies of cost-effectiveness. Archives of Physiotherapy 12:1.
Crossref
Crossref
Meryl Darlington, Raffaele Scarica, Xyomara Chavez-Pacheco, Laeticia Blamplain Segar & Isabelle Durand-Zaleski. (2022) Decrementally cost-effective health technologies in non-inferiority studies: A systematic review. Frontiers in Pharmacology 13.
Crossref
Crossref
Rini Noviyani, Sitaporn Youngkong, Surakit Nathisuwan, Bhavani Shankara Bagepally, Usa Chaikledkaew, Nathorn Chaiyakunapruk, Gareth McKay, Piyamitr Sritara, John Attia & Ammarin Thakkinstian. (2022) Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis. BMJ Evidence-Based Medicine 27:4, pages 215-223.
Crossref
Crossref
Sajesh K. Veettil, Jordi Harris, M. Sakil Syeed, Ammarin Thakkinstian, Usa Chaikledkaew, Daniel M. Witt & Nathorn Chaiyakunapruk. (2022) Incremental net monetary benefit of direct oral anticoagulants for the prevention of venous thromboembolism after total knee or hip replacement: A systematic review and meta-analysis. Thrombosis Research 216, pages 74-83.
Crossref
Crossref
Helen Grover, William King, Nawaraj Bhattarai, Eoin Moloney, Linda Sharp & Liz Fuller. (2022) Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography. Lung Cancer 170, pages 20-33.
Crossref
Crossref
Akhil Sasidharan, Bhavani Shankara Bagepally, S. Sajith Kumar, Kayala Venkata Jagadeesh & Meenakumari Natarajan. (2022) Cost-effectiveness of Ezetimibe plus statin lipid-lowering therapy: A systematic review and meta-analysis of cost-utility studies. PLOS ONE 17:6, pages e0264563.
Crossref
Crossref
Piyameth Dilokthornsakul, Le My Lan, Ammarin Thakkinstian, Raymond Hutubessy, Philipp Lambach & Nathorn Chaiyakunapruk. (2022) Economic evaluation of seasonal influenza vaccination in elderly and health workers: A systematic review and meta-analysis. eClinicalMedicine 47, pages 101410.
Crossref
Crossref
Wenjia Chen, Thunyarat Anothaisintawee, Dimple Butani, Yi Wang, Yaroslava Zemlyanska, Chong Boon Nigel Wong, Suchin Virabhak, M A Hrishikesh & Yot Teerawattananon. (2022) Assessing the cost-effectiveness of precision medicine: protocol for a systematic review and meta-analysis. BMJ Open 12:4, pages e057537.
Crossref
Crossref
Bhavani Shankara Bagepally & Akhil Sasidharan. (2021) Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies. European Journal of Clinical Pharmacology 78:3, pages 351-363.
Crossref
Crossref
Fatma Maraiki, Shouki Bazarbashi, Paul Scuffham & Haitham Tuffaha. (2022) Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review. MDM Policy & Practice 7:1, pages 238146832210868.
Crossref
Crossref
Bhavani Shankara Bagepally, S Sajith Kumar, Meenakumari Natarajan & Akhil Sasidharan. (2022) Incremental net benefit of cholecystectomy compared with alternative treatments in people with gallstones or cholecystitis: a systematic review and meta-analysis of cost–utility studies. BMJ Open Gastroenterology 9:1, pages e000779.
Crossref
Crossref
Edna Keeney, Howard Thom, Emma Turner, Richard M. Martin, Josie Morley & Sabina Sanghera. (2022) Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis. Value in Health 25:1, pages 133-146.
Crossref
Crossref
Irene Lizano-Díez, Jesús Naharro & Ilonka Zsolt. (2021) Indirect costs associated with skin infectious disease in children: a systematic review. BMC Health Services Research 21:1.
Crossref
Crossref
J.K. Peel, S. Keshavjee, M. Krahn & B. Sander. (2021) Economic evaluations and costing studies of lung transplantation: A scoping review. The Journal of Heart and Lung Transplantation 40:12, pages 1625-1640.
Crossref
Crossref
Nikolai Mühlberger, Gaby Sroczynski, Artemisa Gogollari, Beate Jahn, Nora Pashayan, Ewout Steyerberg, Martin Widschwendter & Uwe Siebert. (2021) Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies. The European Journal of Health Economics 22:8, pages 1311-1344.
Crossref
Crossref
Prapaporn Noparatayaporn, Montarat Thavorncharoensap, Usa Chaikledkaew, Bhavani Shankara Bagepally & Ammarin Thakkinstian. (2021) Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences. Obesity Surgery 31:7, pages 3279-3290.
Crossref
Crossref
Kamolpat Chaiyakittisopon, Oraluck Pattanaprateep, Narisa Ruenroengbun, Tunlanut Sapankaew, Atiporn Ingsathit, Gareth J. Mckay, John Attia & Ammarin Thakkinstian. (2021) Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations. The European Journal of Health Economics 22:4, pages 571-584.
Crossref
Crossref
Olena (Lena) Mandrik, J.L. (Hans) Severens, Ariel Bardach, Salah Ghabri, Candyce Hamel, Tim Mathes, Luke Vale, Torbjørn Wisløff & Jeremy D. Goldhaber-Fiebert. (2021) Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report. Value in Health 24:4, pages 463-472.
Crossref
Crossref
Ariuntuya Tuvdendorj, Yihui Du, Grigory Sidorenkov, Erik Buskens, Geertruida H de Bock & Talitha Feenstra. (2020) Informing policy makers on the efficiency of population level tobacco control interventions in Asia: A systematic review of model-based economic evaluations. Journal of Global Health 10:2.
Crossref
Crossref
Angelica Carletto, Matteo Zanuzzi, Annalisa Sammarco & Pierluigi Russo. (2020) Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actions. International Journal of Technology Assessment in Health Care 36:6, pages 560-568.
Crossref
Crossref
Mende Mensa Sorato, Majid Davari, Abbas Kebriaeezadeh, Nasim Naderi, Nizal Sarrafzadegan, Tamiru Shibru, Shekoufeh Nikfar & Amanuel Godana Arero. (2020) Cost-effectiveness of Interventional therapies for management of Treatment-resistant hypertension: systematic review of pharmacoeconomic studies. Journal of Pharmaceutical Health Services Research 11:4, pages 307-319.
Crossref
Crossref
Bhavani Shankara Bagepally, Usa Chaikledkaew, Yogesh Krishnarao Gurav, Thunyarat Anothaisintawee, Sitaporn Youngkong, Nathorn Chaiyakunapruk, Mark McEvoy, John Attia & Ammarin Thakkinstian. (2020) Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies. BMJ Open Diabetes Research & Care 8:1, pages e001020.
Crossref
Crossref
Salah Ghabri, Laurent Lam, François Bocquet & Hans-Martin Spath. (2020) Systematic Literature Review of Economic Evaluations of Biological Treatment Sequences for Patients with Moderate to Severe Rheumatoid Arthritis Previously Treated with Disease-Modifying Anti-rheumatic Drugs. PharmacoEconomics 38:5, pages 459-471.
Crossref
Crossref
Bhavani Shankara Bagepally, Yogesh Krishnarao Gurav, Thunyarat Anothaisintawee, Sitaporn Youngkong, Usa Chaikledkaew & Ammarin Thakkinstian. (2019) Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis. Value in Health 22:12, pages 1458-1469.
Crossref
Crossref
Carolina Castañeda Guerrero, Fernando De la Hoz Restrepo & Nelson Alvis Guzmán. (2019) Calidad en revisiones sistemáticas de evaluaciones económicas de tecnologías en salud.. Panorama Económico 27:3, pages 581-597.
Crossref
Crossref
Thomas Grochtdreis, Hans-Helmut König, Alexander Dobruschkin, Gunhild von Amsberg & Judith Dams. (2018) Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review. PLOS ONE 13:12, pages e0208063.
Crossref
Crossref
Didik Setiawan, Abrham Wondimu, KohJun Ong, Albert Jan van Hoek & Maarten J. Postma. (2018) Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence. PharmacoEconomics 36:8, pages 929-939.
Crossref
Crossref